前列腺SBRT患者报告毒性的剂量学预测因素:基于集成机器学习的全DVH分析
结果显示膀胱剂量体积参数对12个月泌尿刺激和失禁症状有强预测作用(AUC分别为0.79和0.87),而直肠毒性无强剂量学关联(AUC=0.64)。
要点
- 膀胱最大剂量、V102.5%、膀胱体积及适形指数是泌尿HRQOL变化的最强预测因子。
- 膀胱剂量学指标对12个月泌尿刺激症状的AUC为0.79,对失禁症状的AUC为0.87。
- 直肠毒性未发现强剂量学关联,AUC仅为0.64。
核心结论
- 集成机器学习可从全DVH中识别与患者报告泌尿HRQOL变化最相关的剂量学变量,用于制定以结局为导向的放疗计划目标。
研究设计与样本
- 患者报告结局取自SBRT后3个月和12个月的EPIC-26肠道与膀胱症状评分。
- 采用集成机器学习分析全DVH,评估剂量体积参数与HRQOL变化的关系。
主要发现
- 膀胱剂量体积指标强预测12个月患者报告的泌尿刺激症状(AUC=0.79)和失禁症状(AUC=0.87)。
- 膀胱最大剂量、膀胱V102.5%、膀胱体积及适形指数(V50/VPTV和V100/VPTV)对两个泌尿域HRQOL变化最具预测性。
- 未发现直肠毒性的强剂量学关联(AUC=0.64)。
临床怎么用
- 可利用机器学习识别的DVH指标制定以结局为导向的计划目标,以进一步降低前列腺SBRT的患者报告毒性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: This study aims to evaluate the associations between dosimetric parameters and patient-reported outcomes, and to identify latent dosimetric parameters that most correlate with acute and subacute patient-reported urinary and rectal toxicity after prostate stereotactic body radiotherapy (SBRT) using machine learning methods. MATERIALS AND METHODS: Eighty-six patients who underwent prostate SBRT (40 Gy in 5 fractions) were included. Patient-reported health-related quality of life (HRQOL) outcomes were derived from bowel and bladder symptom scores on the Expanded Prostate Cancer Index Composite (EPIC-26) at 3 and 12 months post-SBRT. We utilized ensemble machine learning (ML) to interrogate the entire dose-volume histogram (DVH) to evaluate relationships between dose-volume parameters and HRQOL changes. The latent predictive dosimetric parameters that were most associated with HRQOL changes in urinary and rectal function were thus identified. An external cohort of 26 prostate SBRT patients was acquired to further test the predictive models. RESULTS: Bladder dose-volume metrics strongly predicted patient-reported urinary irritative and incontinence symptoms (area under the curves [AUCs] of 0.79 and 0.87, respectively) at 12 months. Maximum bladder dose, bladder V102.5%, bladder volume, and conformity indices (V50/VPTV and V100/VPTV) were most predictive of HRQOL changes in both urinary domains. No strong rectal toxicity dosimetric association was identified (AUC = 0.64). CONCLUSION: We demonstrated the application of advanced ML methods to identify a set of dosimetric variables that most highly correlated with patient-reported urinary HRQOL. DVH quantities identified with these methods may be used to achieve outcome-driven planning objectives to further reduce patient-reported toxicity with prostate SBRT.
引用
- Pan X, Levin-Epstein R, Huang J, et al. Dosimetric predictors of patient-reported toxicity after prostate stereotactic body radiotherapy: Analysis of full range of the dose-volume histogram using ensemble machine learning. Radiother Oncol. 2020. PMID: 32388444. doi:10.1016/j.radonc.2020.04.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。